| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 4 | |
| #2 | WIPO (World Intellectual Property Organization) | 3 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | Brazil | 1 | |
| #5 | Canada | 1 | |
| #6 | China | 1 | |
| #7 | Israel | 1 | |
| #8 | Japan | 1 | |
| #9 | Mexico | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Plakogiannis Fotios M | 12 |
| #2 | Mcafee Donald | 7 |
| #3 | Borovinskaya Marina | 5 |
| #4 | Lather Tamanna | 5 |
| #5 | Hossain Muhammed Anwar | 5 |
| #6 | Modi Nisarg | 2 |
| #7 | Fotios M Plakogiannis | 2 |
| #8 | Muhammed Anwar Hossain | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2017025912A1 | Aripiprazole compositions and methods for its transdermal delivery | |
| EP3337480A1 | Transdermal delivery of doxylamine succinate and pyridoxine hydrochloride | |
| US2017049714A1 | Transdermal and/or topical delivery system comprising clobazam | |
| US2015342949A1 | Aripiprazole compositions and methods for its transdermal delivery | |
| BR112013010190A2 | pharmaceutical composition |